Cargando…
Achromatopsia: Genetics and Gene Therapy
Achromatopsia (ACHM), also known as rod monochromatism or total color blindness, is an autosomal recessively inherited retinal disorder that affects the cones of the retina, the type of photoreceptors responsible for high-acuity daylight vision. ACHM is caused by pathogenic variants in one of six co...
Autores principales: | Michalakis, Stylianos, Gerhardt, Maximilian, Rudolph, Günther, Priglinger, Siegfried, Priglinger, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766373/ https://www.ncbi.nlm.nih.gov/pubmed/34860352 http://dx.doi.org/10.1007/s40291-021-00565-z |
Ejemplares similares
-
Biology, Pathobiology and Gene Therapy of CNG Channel-Related Retinopathies
por: Gerhardt, Maximilian J., et al.
Publicado: (2023) -
Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis
por: Gerhardt, Maximilian J., et al.
Publicado: (2022) -
AAV-Mediated Gene Supplementation Therapy in Achromatopsia Type 2: Preclinical Data on Therapeutic Time Window and Long-Term Effects
por: Mühlfriedel, Regine, et al.
Publicado: (2017) -
Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
por: Pavlou, Marina, et al.
Publicado: (2021) -
Long-term ocular damage after recovery from COVID-19: lack of evidence at three months
por: Brantl, Victor, et al.
Publicado: (2021)